Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alloy Therapeutics
Biotech
Former Roche oncology head turns to Tubulis—Chutes & Ladders
Former Roche oncology head turns to Tubulis. Argenx CEO passes baton to operating chief. Longtime Charles River leader eyes retirement.
Darren Incorvaia
,
Zoey Becker
Jan 9, 2026 8:30am
Sanofi inks $400M biobucks deal for Alloy's antisense platform
Jan 8, 2025 5:08am
Abbvie's president adds COO title—Chutes & Ladders
Jun 30, 2023 9:30am
New JV from Pyxis, Alloy aims for rapid drug development
May 25, 2021 10:00am
Alloy Therapeutics nabs a $75M series C
Apr 2, 2021 8:55am